Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Christopher Sweeney
Dana Farber Cancer Institute and ANZUP
Study Chair - Ian Davis
ANZUP and Eastern Health Box Hill Hospital
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
82 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Chris O'Brien Lifehouse
Camperdown, New South Wales, Australia
- Coffs Harbour Health Campus
Coffs Harbour, New South Wales, Australia
- Concord Cancer Centre - Concord Repatriation General Hospital
Concord, New South Wales, Australia
- St Vincent'S Hospital Sydney
Darlinghurst, New South Wales, Australia
- Nepean Cancer Care Centre
Kingswood, New South Wales, Australia
- St. George Hospital
Kogarah, New South Wales, Australia
- Central West Cancer Services
Orange, New South Wales, Australia
- Port Macquarie Base Hospital
Port Macquarie, New South Wales, Australia
- Prince of Wales Hospital
Randwick, New South Wales, Australia
- Genesis Care North Shore
St Leonards, New South Wales, Australia
- Tamworth Rural Referral Hospital
Tamworth, New South Wales, Australia
- the Tweed Hospital
Tweed Heads, New South Wales, Australia
- Riverina Cancer Care Centre
Wagga Wagga, New South Wales, Australia
- Sydney Adventist Hospital
Wahroonga, New South Wales, Australia
- Wollongong Hospital
Wollongong, New South Wales, Australia
- Royal Darwin Hospital
Tiwi, Northern Territory, Australia
- Sunshine Coast University Hospital
Birtinya, Queensland, Australia
- Townsville Hospital
Douglas, Queensland, Australia
- Royal Brisbane and Women'S Hospital
Herston, Queensland, Australia
- Gold Coast University Hospital
Southport, Queensland, Australia
- Princess Alexandra Hospital
Woolloongabba, Queensland, Australia
- Royal Adelaide Hospital
Adelaide, South Australia, Australia
- Flinders Medical Centre
Bedford Park, South Australia, Australia
- Adelaide Cancer Centre - Ashford Cancer Care Centre
Kurralta Park, South Australia, Australia
- Royal Hobart Hospital
Hobart, Tasmania, Australia
- Bendigo Hospital
Bendigo, Victoria, Australia
- Monash Cancer Centre Moorabbin
Bentleigh East, Victoria, Australia
- Peter Maccallum Cancer Centre - East Melbourne
East Melbourne, Victoria, Australia
- St. Vincents Hospital Melbourne
Fitzroy, Victoria, Australia
- Peninsula South Eastern Haematology & Oncology Group- Peninsula Oncology Centre
Frankston, Victoria, Australia
- University Hospital Geelong
Geelong, Victoria, Australia
- Austin Hospital
Heidelberg, Victoria, Australia
- Australian Urology Associates
Malvern, Victoria, Australia
- Eastern Health Box Hill Hospital
Melbourne, Victoria, Australia
- Goulburn Valley Health
Shepparton, Victoria, Australia
- Border Medical Oncology
Wodonga, Victoria, Australia
- Sir Charles Gairdner Hospital
Nedlands, Western Australia, Australia
- Fiona Stanley Hospital (formerly Royal Perth Hospital)
Perth, Western Australia, Australia
- Prostate Cancer Institute - Southern Alberta Institute of Urology
Calgary, Alberta, Canada
- Cross Cancer Institute
Edmonton, Alberta, Canada
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2014
- Primary completion
- 31 Dec 2026
- Completion
- 30 Jun 2027
- Last update posted
- 6 Feb 2025
- Registered enrollment
- 1,125
- Registry id
- NCT02446405
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.